Immunostaining and EMSA revealed that NF-jB was activated strongly by TNF/IFN-a compared to TNF alone in a human colon adenocarcinoma cell line, RPMI4788. Although inhibition of activated NF-jB, by using an NF-jB decoy, reduced cell viability after treatment with TNF only, NF-jB decoy resulted in recovery of cell viability after TNF/IFN-a treatment. Caspase-3 activity was increased in cells induced by TNF/IFNa, while suppression of caspase-3 activity was observed in cells transfected with NF-jB decoy and then treated by TNF/ IFN-a. On the other hand, Fas expression was strongly enhanced by TNF/IFN-a, and inhibition of TNF/IFN-a-induced NF-jB activation, by using NF-jB decoy, decreased Fas expression. Cell viability and caspase-3 activity decreased in cells treated with TNF/IFN-a and anti-FasL antibody. Taken together, our findings suggest that activated NF-jB induced by the crosstalk between TNF and IFN-a is a novel proapoptotic signal acting via enhancement of Fas expression.